Montana State University   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Bozeman MT United States (1893)

Organization Overview

First Clinical Trial
2015
NCT02568878
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Montana State University

Active Ingredients

Drugs in Phase 3 Trials (1)

creatine (1 trial)

Drugs in Phase 1 Trials (1)

tetrahydrocannabinol (1 trial)

Drugs in Other Trials (3)

aronia juice (1 trial)

branched chain amino acids (1 trial)

cannabis (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 3)

Marijuana Abuse (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5